STACEY OLIVIER: Open Payments
NPI 1427126523 · GRAND RAPIDS, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,032 in 45 payments from 14 companies in 2025. Trend: 2023 $809 · 2024 $708 · 2025 $1,032
Food & beverage: $1,032
| Company | Payments | Amount |
|---|---|---|
| E.R. Squibb & Sons, L.L.C. | 10 | $205 |
| Novartis Pharmaceuticals Corporation | 7 | $173 |
| GENZYME CORPORATION | 6 | $135 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 1 | $106 |
| Lilly USA, LLC | 5 | $96 |
| ABBVIE INC. | 4 | $85 |
| UCB, Inc. | 3 | $58 |
| Incyte Corporation | 2 | $55 |
| Regeneron Healthcare Solutions, Inc. | 1 | $28 |
| Organon LLC | 2 | $26 |
Products named: Sotyktu, COSENTYX, DUPIXENT, Winlevi, EBGLYSS, Bimzelx, OPZELURA, RINVOQ.
Industry payments across MI — which companies pay providers there.
